Uncategorized
FDA approves Pfizer and Arvinas’ breast cancer drug despite underwhelming data
FDA approves Pfizer and Arvinas’ breast cancer drug despite underwhelming data
The FDA on Friday approved Pfizer and Arvinas’ drug vepdegestrant for patients with a certain form of breast cancer. But it’s unclear how many will take it.
The drug will be … Read More